📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Arsanis

1.1 - Company Overview

Arsanis Logo

Arsanis

Headquarter: Austria
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical infectious disease treatments based on bacterial protein and carbohydrate antigens.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Arsanis

TG Therapeutics Logo

TG Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for hematologic malignancies and autoimmune disorders, including BRIUMVI, a treatment for relapsing forms of multiple sclerosis—clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease—in adults.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TG Therapeutics company profile →
Affimed Logo

Affimed

HQ: Germany Website
  • Description: Provider of innate cell engager (ICE) antibody therapeutics for cancer, including AFM13 (CD30/CD16A), AFM24 (EGFR-directed engaging NK cells and macrophages), and AFM28 (CD123/CD16A for AML), plus the ROCK platform for customizable ICEs, ongoing clinical trials, and partnerships with pharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affimed company profile →
Selexys Pharmaceuticals Logo

Selexys Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutics under development for inflammatory and thrombotic diseases, targeting the underlying disease mechanism—adhesion of white blood cells to sites of inflammation mediated by P-selectin binding; privately held.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Selexys Pharmaceuticals company profile →
Exacis Logo

Exacis

HQ: United States Website
  • Description: Provider of development-stage immuno-oncology solutions, using mRNA-based cell reprogramming to create iPSC and mRNA-based gene editing to engineer iPSC, creating engineered NK and T cells designed to resist host immune rejection to harness the human immune system against cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exacis company profile →
ISA Pharmaceuticals Logo

ISA Pharmaceuticals

HQ: The Netherlands Website
  • Description: Provider of clinical-stage, fully synthetic immunotherapeutics and therapeutic vaccines for cancer and persistent viral infections, built on its Synthetic Long Peptide (SLP®) and AMPLIVANT® platforms; products include ISA101b for HPV16-induced cancers and ISA104 for chronic hepatitis B infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ISA Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Arsanis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Arsanis

2.2 - Growth funds investing in similar companies to Arsanis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Arsanis

4.2 - Public trading comparable groups for Arsanis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Arsanis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Arsanis

What does Arsanis do?

Arsanis is a provider of biopharmaceutical infectious disease treatments based on bacterial protein and carbohydrate antigens.

Who are Arsanis's competitors?

Arsanis's competitors and similar companies include TG Therapeutics, Affimed, Selexys Pharmaceuticals, Exacis, and ISA Pharmaceuticals.

Where is Arsanis headquartered?

Arsanis is headquartered in Austria.

How many employees does Arsanis have?

Arsanis has 1,000 employees 🔒.

When was Arsanis founded?

Arsanis was founded in 2010 🔒.

What sector and industry vertical is Arsanis in?

Arsanis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Arsanis

Who are the top strategic acquirers in Arsanis's sector and industry

Top strategic M&A buyers and acquirers in Arsanis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Arsanis?

Top strategic M&A buyers groups and sectors for Arsanis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Arsanis's sector and industry vertical

Which are the top PE firms investing in Arsanis's sector and industry vertical?

Top PE firms investing in Arsanis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Arsanis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Arsanis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Arsanis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Arsanis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Arsanis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Arsanis?

The key public trading comparables and valuation benchmarks for Arsanis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Arsanis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Arsanis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Arsanis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Arsanis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Arsanis's' sector and industry vertical?

Access recent funding rounds and capital raises in Arsanis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Arsanis